Product Information
VENLAFAXINE HCL ER 225 MG TAB is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.4967 per EA under NDC 47335079483. Its NADAC has been published 355 times since May 8, 2019.
FDA first approved this application on Aug 18, 2010.
Strength
225 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
47335079483
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA091272FDA Approved
8/18/2010
On Market Since
2/15/2019
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL ER 225 MG TAB has been published 355 times since May 8, 2019, and over the history we have for it it has declined 95.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4967 per EA |
|---|---|
| All-time high | $10.8041 (Jul 10, 2019) |
| All-time low | $0.4592 (Nov 20, 2024) |
| 52-week high | $0.6770 |
| 52-week low | $0.4964 |
| Median price | $1.8582 |
| Average price | $3.3319 |
| Largest weekly change | +54.1% (Feb 22, 2023) |
| Weeks tracked | 355 |
| Tracking since | May 8, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-26.6%
3Y
-42.7%
5Y
-85.7%
All
-95.0%
Last surveyed Feb 18, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL ER 225 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL ER 225 MG TAB, manufactured by Sun Pharmaceutical Industries Inc., is $0.4967 per EA (NDC 47335079483), effective Feb 18, 2026.
How has the price of VENLAFAXINE HCL ER 225 MG TAB changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL ER 225 MG TAB has declined 95.0%. It has been tracked across 355 weekly CMS publications since May 8, 2019.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL ER 225 MG TAB?
Since May 8, 2019, the NADAC for VENLAFAXINE HCL ER 225 MG TAB has ranged from a low of $0.4592 (Nov 20, 2024) to a high of $10.8041 (Jul 10, 2019), with a median of $1.8582 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL ER 225 MG TAB?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VENLAFAXINE HCL ER 225 MG TAB, is $0.4614 per EA — about 7% below VENLAFAXINE HCL ER 225 MG TAB.
Who manufactures VENLAFAXINE HCL ER 225 MG TAB?
VENLAFAXINE HCL ER 225 MG TAB (NDC 47335079483) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.